Celcuity Inc.
NASDAQ:CELC · NASDAQ Capital Market
-$4.04 today
Vol 1.83M · Avg 1.24M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+666.46%
Period High
$144.98
Period Low
$11.45
Latest
$87.76
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.16B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.45B
Legend Biotech Corporation
NASDAQ:LEGN
$5.43B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.39B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.08B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.18B
Disc Medicine, Inc.
NASDAQ:IRON
$2.70B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.70B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
Ascentage Pharma Group International
NASDAQ:AAPG
$403.00M
What is the latest CELC filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does CELC have?
Intrinsic Alpha currently shows 20 recent filings for CELC.
Explore More
Continue the stock analysis
Jump to another research area for this company.